Arcadia Biosciences’ CEO Matt Plavan tells Proactive that the agricultural technology company has raised about $6.8 million by selling warrants. Plavan says the company expects to use the proceeds to pursue a range of near-term inorganic growth opportunities within its hemp business unit as well as a cushion from corona virus. Plavan also discussed its most recent quarterly earnings.

View Source (Proactive Investors)

Leave a Comment

Your email address will not be published. Required fields are marked *